Feature | March 18, 2014

Document Addresses PCI Quality, Safety

March 18, 2014 — The increasing number of percutaneous coronary interventions (PCIs) being performed at low-volume centers without on-site cardiac surgery backup has driven the need for new safety and quality protocols. This is according to an expert consensus document written by a committee representing the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA). The document outlines steps hospitals can take to provide the safest possible environment for PCI when the facility does not provide cardiac surgery as a backup should complications occur.

"This issue was last reviewed in 2007, and since that time interventional cardiology has seen important changes," said Gregory J. Dehmer, M.D., FACC, FSCAI, director of the Division of Cardiology at Baylor Scott & White Health, Central Texas (Temple, Texas) and the document's lead author. "The new recommendations aim to increase safety while maintaining access to quality care for underserved patients."

Although PCI use increased significantly since the procedure was introduced more than 30 years ago, for a variety of reasons use peaked in 2006 and has since dropped by nearly a third. Advances in drug-eluting stents, greater use of medication to treat some types of blockages, increased emphasis on heart disease prevention, and new technologies to help physicians better evaluate blockages have all contributed to a drop in PCI use.

This drop has led to an increase in the number of facilities that are considered "low volume," or performing fewer than 200 PCIs per year, according to the consensus document. Overall, one-third of facilities performing PCI had no on-site cardiac surgery, and among those hospitals, about two-thirds were considered low volume.

The consensus document cites studies and meta-analyses since 2006 that find no indication of increased mortality or a greater need for emergency bypass surgery for either heart attack or elective PCI patients at sites without on-site cardiac surgery. In general, it said, safety questions about sites without surgical backup have diminished "in the presence of a proven, well-defined and protocol-driven approach."

However, the paper echoed an earlier joint recommendation that low-volume PCI programs "must have stringent systems and process protocols in place" with close monitoring of outcomes and strategies that encourage collaboration with higher-volume facilities.

"As the technique and equipment for PCI has improved, the evidence from randomized studies suggests that procedures can be performed safely without on-site surgery," said Dehmer. "But at the same time, the number of low-volume centers is increasing, making it essential that those facilities without backup cardiac surgery have strict protocols in place to ensure the highest level of patient safety."

The consensus document compiles the recommendations made by various organizations in several different documents into one resource for use by facilities without on-site surgery. These include a greater emphasis on quality review programs, the recommended number of procedures physicians should perform per year to maintain their skills, mentoring for newly trained cardiologists and criteria to evaluate PCI programs. It also recommends a shift in focus to system-wide planning for rational distribution of PCI services.

"The expansion of small PCI programs without on-site surgery has not substantially improved access to PCI," said Dehmer. "Although the number of facilities capable of performing PCI has increased 44 percent, the number of people who live within a one-hour drive of a PCI facility has increased only slightly. Today about 80 percent of the population is within one-hour of a PCI hospital." Recent surveys found expansion of PCI reduced drive times for just 9 percent of the population.

The document also supports the ongoing study and surveillance of all PCI programs through participation in national databases, encourages public reporting of results and acknowledges further declines in PCI volumes might necessitate the closure of some PCI programs in the future.

The consensus document, titled, "SCAI/ACCF/AHA Expert Consensus Document Update on Percutaneous Coronary Intervention without On-Site Surgical Backup," updates a 2007 consensus document. It was published online in Catheterization & Cardiovascular Interventions, Journal of the American College of Cardiology (JACC) and Circulation: Journal of the American Heart Association.

For more information: onlinelibrary.wiley.com

Related Content

Synergy stent
Technology | October 05, 2015
October 5, 2015 — The U.S.
Tryton Side Branch Stent, clinical trial results, Catheterization and Cardiovascular Interventions

Tryton Side Branch Stent image courtesy of Tryton Medical

News | Stents Bifurcation| October 02, 2015
October 2, 2015 — Tryton Medical Inc.
Brilinta, 60 mg dose available, U.S. pharmacies
Technology | Antiplatelet and Anticoagulation Therapies| October 02, 2015
AstraZeneca announced that Brilinta (ticagrelor) 60-mg tablets are now available in U.S. pharmacies. On Sept. 3, 2015,...
Intact Vascular, TOBA II study, Tack Endovascular System

Image courtesy of Intact Vascular

News | Peripheral Arterial Disease (PAD)| October 01, 2015
Intact Vascular Inc. announced the U.S. Food and Drug Administration has granted conditional approval for a U.S. and...
Cook Medical, Zilver PTX, Japan PMS study, CIRSE 2015, two-year results

Image courtesy of Cook Medical

News | Stents Peripheral| October 01, 2015
Kimihiko Kichikawa, M.D., department of radiology at Nara Medical University in Japan, reported two-year results of the...
Stentys, CE Mark for self-apposing stent, lower limb artery disease, below-the-knee arteries, critical limb ischemia, PES BTK-70 trial

Image courtesy of Stentys

News | Stents Peripheral| October 01, 2015
Stentys announced that the company’s drug-eluting stent received CE Mark for treatment of below-the-knee (BTK) arteries...
raysafe, i2, staff dose monitoring
News | Radiation Dose Management| October 01, 2015
October 1,2015 — The first and only system that delivers real-time X-ray radiation dose monitoring for physicians and
News | Cath Lab| September 29, 2015
The Innovation Institute announced that Boston Scientific has signed an agreement to become the founding medical device...
News | Antiplatelet and Anticoagulation Therapies| September 25, 2015
The Icahn School of Medicine at Mount Sinai has launched the international TWILIGHT clinical trial to test the safety...
CeloNova BioSciences, Cobra PzF coronary stent system, second randomized trial, COBRA-REDUCE

Cobra PzF coronary stent system image courtesy of CeloNova BioSciences Inc.

News | Stents| September 23, 2015
CeloNova BioSciences Inc. announced that it has received conditional approval to start an investigational device...
Overlay Init